2026-01-20 - Analysis Report
**Company Overview**
Freeport-McMoRan is a leading international mining company with operations in the United States, Indonesia, and South America.

**Return Rate Comparison**

* Cumulative return of review stock (FCX) = 191.94%
* Cumulative return of comparison stock (S&P 500, VOO) = 93.30%
* Divergence (max: 175.30, min: -44.10, current: 98.60, relative divergence: 65.00%)

The cumulative return of FCX is significantly higher than that of S&P 500, indicating a higher divergence.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -23.0% | 41.3% | -28.0% | 1.9 | 14.8B |
| 2017-2019  | -63.0% | 41.3% | -80.0% | 1.6 | 18.8B |
| 2018-2020  | 36.0% | 41.3% | 15.0% | 1.6 | 37.4B |
| 2019-2021  | 189.0% | 29.3% | 146.0% | 1.6 | 59.9B |
| 2020-2022  | 150.0% | 32.5% | 152.0% | 1.6 | 54.6B |
| 2021-2023  | 21.0% | 32.5% | 20.0% | 1.5 | 61.1B |
| 2022-2024  | -59.0% | 32.5% | -78.0% | 1.4 | 54.7B |
| 2023-2025  | -1.0% | 29.1% | -63.0% | 1.5 | 72.9B |

The Alpha and Beta values indicate moderate to high volatility in the past periods.

**Recent Stock Price Fluctuations**

* Close = $58.71 
* 5-day SMA = $59.42
* 20-day SMA = $54.21
* 60-day SMA = $46.35

The stock price is slightly above the 20-day SMA and below the 5-day SMA, indicating a rebound.

**Rising Trend Analysis**

* Market Risk Indicator (MRI) = 0.80
* RSI = 66.29
* PPO = 0.40
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.80)
* Recent (20 days) relative divergence change = 5.20 (+): improving
* 7-day Rank change = 9 (+): rank up
* 7-day Dynamic Expected Return change = -0.80 (-): worsening

The indicators suggest a moderate to high risk, with the RSI and PPO indicating a buy signal.

**Recent Fluctuation Issue**
The recent fluctuation issue is characterized by a sharp decline in the last 20 days.

**Expected Return**
Expected Return (%) = 47.40%, Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

**Recent News & Significant Events**

[2026-01-06] Freeport-McMoRan (FCX) Valuation Check After Recent Share Price Momentum - Yahoo Finance
[2026-01-19] Can Freeport-McMoRan's Project Pipeline Power the Next Growth Wave? - TradingView
[2026-01-19] Csenge Advisory Group Has $1.21 Million Position in Freeport-McMoRan Inc. $FCX - MarketBeat
[2026-01-15] Copper Miner Freeport-McMoRan's Earnings Are Due. Take Advantage Of Volatility Around The Report. - Investor's Business Daily
[2026-01-14] Freeport-McMoRan Stock: Huge Breakout. Now What? (NYSE:FCX) - Seeking Alpha
[2025-12-24] Here's Why You Should Retain Freeport-McMoRan Stock in Your Portfolio - Yahoo Finance

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.76 (~Buy)
- Opinions: 20
- Target Price (avg/high/low): 57.70 / 69.00 / 25.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|---:|------:|
| 2025-11-06 | 0.46 | 6.82 B$ |
| 2025-08-08 | 0.53 | 7.53 B$ |
| 2025-05-08 | 0.24 | 5.57 B$ |
| 2024-11-08 | 0.36 | 6.68 B$ |
| 2025-11-06 | 0.36 | 6.68 B$ |

The EPS and revenue have fluctuated in the past periods, with the last earnings indicating a moderate recovery.

**Financial Information**

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $6.97B | 30.72% |
| 2025-06-30 | $7.58B | 34.71% |
| 2025-03-31 | $5.73B | 26.29% |
| 2024-12-31 | $5.72B | 24.91% |
| 2024-09-30 | $6.79B | 31.12% |

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $18.68B | 3.61% |
| 2025-06-30 | $18.21B | 4.24% |
| 2025-03-31 | $17.69B | 1.99% |
| 2024-12-31 | $17.58B | 1.56% |
| 2024-09-30 | $17.55B | 3.00% |

The revenue and profit margin have fluctuated in the past periods, with the last quarter indicating a moderate recovery.

**Comprehensive Analysis (Summary)**
Freeport-McMoRan has a significant cumulative return, but the recent fluctuation issue suggests a rebound in the stock price. The Alpha and Beta values indicate moderate to high volatility. The risk level is medium, with the RSI and PPO indicating a buy signal. The expected return is 47.40%, and the recent earnings and financial information suggest a moderate recovery. The company has a strong analyst consensus with a mean rating of 1.76 and a target price range of $57.70 to $69.00.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.